Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Abrahamsen

Showing results (41-50 of 211) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|April 24, 2009
More on reports of esophageal cancer with oral bisphosphonate useBo Abrahamsen, Pia Eiken, Richard Eastell
Archives of Internal Medicine|February 16, 2011
Proton pump inhibitor use and the antifracture efficacy of alendronateBo Abrahamsen, Pia Eiken, Richard Eastell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2008
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort studyBo Abrahamsen, Pia Eiken, Richard Eastell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 10, 2015
Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription DataBo Abrahamsen, Clive Osmond, Cyrus Cooper
British Journal of Clinical Pharmacology|September 8, 2018
Side effects of drugs for osteoporosis and metastatic bone diseaseMichael Kriegbaum Skjødt, Morten Frost, Bo Abrahamsen
Expert Opinion on Drug Discovery|February 5, 2014
Status of drug development for the prevention and treatment of osteoporosisPeter Schwarz, Niklas Rye Jørgensen, Bo Abrahamsen
Calcified Tissue International|April 5, 2021
Epidemiology of Tumor-Induced Osteomalacia in DenmarkBo Abrahamsen, Christopher D Smith, Salvatore Minisola
Ugeskrift for Laeger|May 13, 2011
[New online tool for assessment of the risk of osteoporotic fractures]Bo Abrahamsen, Katrine Hass Rubin, Kim Brixen
Bone|December 25, 2018
Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture preventionBo Abrahamsen, Michael K Skjødt, Peter Vestergaard
Ugeskrift for Laeger|March 26, 2005
[Osteoporosis in men--diagnosis and treatment]Bo Abrahamsen, Lars Hyldstrup, Kim T Brixen
Pageof 22

Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|April 24, 2009
More on reports of esophageal cancer with oral bisphosphonate useBo Abrahamsen, Pia Eiken, Richard Eastell
Archives of Internal Medicine|February 16, 2011
Proton pump inhibitor use and the antifracture efficacy of alendronateBo Abrahamsen, Pia Eiken, Richard Eastell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2008
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort studyBo Abrahamsen, Pia Eiken, Richard Eastell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 10, 2015
Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription DataBo Abrahamsen, Clive Osmond, Cyrus Cooper
British Journal of Clinical Pharmacology|September 8, 2018
Side effects of drugs for osteoporosis and metastatic bone diseaseMichael Kriegbaum Skjødt, Morten Frost, Bo Abrahamsen
Expert Opinion on Drug Discovery|February 5, 2014
Status of drug development for the prevention and treatment of osteoporosisPeter Schwarz, Niklas Rye Jørgensen, Bo Abrahamsen
Calcified Tissue International|April 5, 2021
Epidemiology of Tumor-Induced Osteomalacia in DenmarkBo Abrahamsen, Christopher D Smith, Salvatore Minisola
Ugeskrift for Laeger|May 13, 2011
[New online tool for assessment of the risk of osteoporotic fractures]Bo Abrahamsen, Katrine Hass Rubin, Kim Brixen
Bone|December 25, 2018
Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture preventionBo Abrahamsen, Michael K Skjødt, Peter Vestergaard
Ugeskrift for Laeger|March 26, 2005
[Osteoporosis in men--diagnosis and treatment]Bo Abrahamsen, Lars Hyldstrup, Kim T Brixen
Pageof 22